Article
ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State
17 Oct 2019
Abstract excerpt
Abstract 13-Cis-retinoic acid (RA) is typically used in postremission maintenance therapy in patients with neuroblastoma. However, side effects and recurrence are often observed. We investigated the use of miRNAs as a strategy to replace RA as promoters of differentiation. miR-124 was identified as the top candidate in a functional screen. Genomic target analysis indicated that repression of a network of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
